Index | Ligand Name | Structure | PDB code | Compound Potency nM |
1 | 4a9 | Type II Dasatinib Analog Crystallized with c-Src Kinase | 4ybj | 0.53 |
2 | 0jn | Crystal structure of 1NM-PP1 bound to analog-sensitive Src kinase | 4lgh | 2 |
3 | h8h | Src kinase in complex with a quinazoline inhibitor | 2h8h | 2.7 |
4 | vgg | Structure of 3MB-PP1 bound to analog-sensitive Src kinase | 4lgg | 3 |
5 | 1n1 | Kinase domain of cSrc in complex with Dasatinib | 3g5d | 11 |
6 | 4b7 | C-Helix-Out Dasatinib Analog Crystallized with c-Src Kinase | 4ybk | 15 |
7 | pd5 | Crystal structure of c-Src in complex with pyrazolopyrimidine 5 | 3el8 | 25 |
8 | 56g | Kinase domain of cSrc in complex with RL235 | 5d11 | 28 |
9 | g97 | Kinase domain of cSrc in complex with RL40 | 5d12 | 43 |
10 | 563 | Kinase domain of cSrc in complex with RL236 | 5d10 | 72 |
11 | djk | Crystal structure of Src kinase domain in complex with covalent inhibitor PD168393 | 2hwp | 73 |
12 | vsp | Crystal Structure of T338C c-Src covalently bound to vinylsulfonamide-pyrazolopyrimidine 9 | 3svv | 114 |
13 | djk | Drug resistant cSrc kinase domain in complex with covalent inhibitor PD168393 | 3lok | 120 |
14 | rbs | Crystal structure of Src kinase domain in complex with covalent inhibitor | 2hwo | 126 |
15 | 11v | Kinase domain of cSrc in complex with a substituted pyrazolopyrimidine | 4o2p | 200 |
16 | pd3 | Crystal structure of c-Src in complex with pyrazolopyrimidine 3 | 3el7 | 480 |
17 | i76 | c-SRC kinase domain in complex with RM-1-176 | 4dgg | 800 |
18 | mpz | Structure of unphosphorylated c-Src in complex with an inhibitor | 1y57 | 1633 |
19 | sr2 | Crystal structure of drug resistant SRC kinase domain with irreversible inhibitor | 2qq7 | 5710 |
20 | sti | Crystal Structure of chicken c-Src kinase domain in complex with the cancer drug imatinib. | 2oiq | 1e+004 |
21 | b5a | c-SRC kinase domain in complex with bumpless BKI analog UW1243 | 3uqg | 1e+004 |
22 | bk5 | c-SRC kinase domain in complex with BKI RM-1-89 | 3uqf | 2e+004 |